Pain Management Devices Market, Size, Share, Growth, Future Prospects, and Competitive Analysis, 2024-2032

Pain Management Devices Market, by Product Type (Spinal Cord Stimulation (SCS) Devices, Stimulated Neuromodulator Devices, and Transcutaneous Electrical Nerve Stimulation (TENS) Devices), by Ablation Devices (Cryoablation Devices, Radiofrequency Ablation Devices, Analgesia Infusion Pumps, External Infusion pumps, and Intrathecal Infusion Pumps), by Application (A migraine, Cancer Pain, Neuropathic Pain, Musculoskeletal Pain, Facial, Trauma, and Others), and by Region (North America, South America, Europe, Asia Pacific, The Middle East and Africa) - Size, Share, COVID Impact Analysis, Growth, Outlook, and Opportunity Analysis

Medical tools used to assist manage both chronic and acute pain are known as pain management equipment. These gadgets function by sending precise electrical or chemical stimulation to the nerves or tissues that are in charge of carrying pain signals to the brain. Spinal cord stimulation, neuromodulation, and infusion pumps are a few of the several kinds of pain management equipment. Due to the rising prevalence of chronic pain problems and the rising need for non-invasive pain management techniques, the market for pain management devices has been expanding recently.

Advancement in technology and Rising healthcare expenditure are the drivers, but high cost of pain management devices is the restraint

Innovations in pain management technology and technological improvements as a whole have made a significant impact on the market's expansion. For instance, it is now possible to manage pain more successfully and with fewer side effects because of the invention of less invasive and implanted pain management technologies such spinal cord stimulators, neuromodulators, and analgesia infusion pumps. The market has also benefited from an increase in healthcare spending and increased investment by major companies in the market for pain management devices. For instance, the healthcare industry has seen significant investment from governments and commercial organisations around the world, which has prompted the development of cutting-edge medical technologies and gadgets, including pain management devices. For instance, the Centres for Medicare and Medicaid Services (CMS) in the United States changed the rates of reimbursement at which it pays for spinal cord stimulator procedures, which encouraged healthcare professionals to use pain management devices more frequently.

On the other hand, one of the main market limitations is the high cost of pain management devices and related procedures. Some patients, particularly in developing nations, may not be able to pay them because of this. Patients' costs are increased by some countries' stringent reimbursement regulations for pain management devices. For instance, Strict eligibility requirements for various procedures set by the National Health Service (NHS) in the UK restrict patient access to SCS devices. The expense burden for patients who require this treatment is further increased by the UK's restrictive reimbursement policies for pain management devices.

Spinal Cord Stimulation (SCS) segment is expected to account for significant market share by product type segment

The global Pain Management Devices market is mainly classified based on Product Type, Ablation Devices, and Application. Based on the product type, the market is segmented into spinal cord stimulation (SCS) devices, stimulated neuromodulator devices, and transcutaneous electrical nerve stimulation (TENS) devices. On the basis of ablation devices, the market is classified into cryoablation devices, radiofrequency ablation devices, analgesia infusion pumps, external infusion pumps, and intrathecal infusion pumps. By Application, the market is segmented into a migraine, cancer pain, neuropathic pain, musculoskeletal pain, and Others like facial, and trauma, etc.

Based on product type, the spinal cord stimulation (SCS) devices market segment held the largest market share in the Pain Management Devices market. There are a number of factors that could contribute to the SCS devices segment dominating the market. First of all, SCS devices have a long history of use and a shown record of safety and effectiveness in treating chronic pain problems. Second, technological developments have reduced the size, increased the flexibility, and raised the customizability of SCS devices, which has improved patient comfort and outcomes. Last but not least, SCS devices offer a variety of uses, from controlling complicated regional pain syndrome to treating chronic back pain, which has boosted its appeal among patients and healthcare professionals. The companies are introducting variety of SCS devices globally. For instances, Abbott Laboratories, a leader in the worldwide medical technology industry, provides a variety of SCS devices, including the ProclaimTM XR recharge-free SCS system. Abbott announced in 2021 that the ProclaimTM XR SCS system had been given the US FDA's blessing for the treatment of chronic pain, further solidifying the business's position in the SCS industry.

Interesting Facts of Pain Management Devices Market:

• Based on the application, the largest market share in the market for pain management devices was being held by the neuropathic pain category.
• On the basis of ablation devices, the radiofrequency ablation devices segment had the majority of the market share in the Pain Management Devices market. Radio waves are used in radiofrequency ablation devices to generate heat and kill nerve tissue that transmits pain signals to the brain, thereby lessening pain.
• The market for pain relief devices is dominated by North America, with Europe and the Asia-Pacific area coming in second and third. This occurs due to the high prevalence of chronic pain disorders, a strong healthcare system, and the presence of significant players in the area.
• Some of the new developments in the market include the creation of wireless pain management devices and the use of artificial intelligence (AI) and machine learning (ML) technology.
• Medtronic, Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, and St. Jude Medical are important market participants for pain management devices. In order to develop advanced pain treatment products and increase their market share, these businesses are investing in R&D.

North America will account for the largest share of the Pain Management Devices industry

North America is anticipated to dominate the market for pain management devices due to a number of factors, including the high prevalence of chronic pain conditions, the presence of key players in the area, and a robust healthcare infrastructure that supports the adoption of advanced pain management technologies. For instance, The Cleveland Clinic, a top healthcare organisation in the nation, recently announced the inauguration of a new Centre for Pain Management that would offer patients with complicated pain disorders modern pain management services. The facility provides a variety of innovative pain management technologies, including as SCS devices and other neuromodulation equipment, in addition to individualised treatment programmes that are catered to the specific requirements of each patient.

The companies in this region are focusing on research and investing its time on the development of pain management devices. For instance, Medtronic has been making investments in R&D to enhance its pain management devices, such as creating a new spinal cord stimulation therapy that is intended to offer greater pain relief and enhance patient results. Adding to this, Abbott Laboratories additionally makes investments in research and development to enhance its pain management devices, such as creating a new DRG stimulation therapy that is intended to deliver focused pain relief to people with chronic pain problems.

Global Pain Management Devices Market key Players:

Some of the major competitors in the global Pain Management Devices market include AGCO Corporation, AgEagle Aerial Systems Inc., Bayer CropScience AG, Case IH Agriculture (CNH Industrial America LLC.), DTN (CLEAR AG SOLUTIONS), Conservis Corporation, Gamaya SA, Easytosee Agtech, Microsoft Corporation, IBM Corporation, Hummingbird Technologies Limited, Deere & Company, Raven Industries, Topcon Positioning Systems, and Trimble Inc.

The Pain Management Devices industry is extremely competitive with aggressive market strategies of global and regional companies looking to strengthen market position through new product launches, collaborations, and facility expansions. The following are some recent market developments:

• In January 2021, Medtronic introduced the the Vanta implantable neurostimulator. It utilises the company's AdaptiveStim patented technology to provide individualised pain management therapy.
• Boston Scientific purchased Cosman Medical in August 2020 to increase the scope of its pain management offerings. Cosman Medical produces radiofrequency ablation systems for the treatment of chronic pain.
• In June 2020, Abbott Laboratories received FDA approval for its Proclaim XR spinal cord stimulation system, which provides users with up to ten years of battery life and individualised pain management via Bluetooth connectivity.
• The Neurotherm Radiofrequency Generator, a tool for pain treatment in minimally invasive procedures, was introduced in China in May 2021, according to a release from Lepu Medical Technology (Beijing) Co., Ltd.
• Nalu Medical, a manufacturer of wireless neuromodulation devices, raised $26 million in Series B funding in March 2020 to accelerate the development of its pain treatment technology.
• Quirem Medical, a Dutch business that creates radiation microspheres for pain relief and cancer treatment, was acquired by Terumo Corporation in December 2020.

Frequently asked questions about global Pain Management Devices Market

Q: What are the major opportunities in Pain Management Devices industry?
Ans: The development of wireless pain management devices and the integration of AI and ML technologies in pain management devices are major opportunities in the industry.

Q: What is the major driving factor for Pain Management Devices industry?
Ans: The increasing prevalence of chronic pain conditions is the major driving factor for the Pain Management Devices industry.

Q: Which region is expected to have the largest share of the Pain Management Devices market?
Ans: North America region is expected to have the largest share of the Pain Management Devices market.

Q: Which application segment will dominate the Pain Management Devices market?
Ans: Neuropathic pain segment is expected to dominate the pain management devices market by application.

1. Pain Management Devices Market - Introduction

1. Market Definition

2. Research Objective and Scope of the Report

2. Pain Management Devices Market - Research Methodology

3. Pain Management Devices Market - Executive Summary

1. Market Snippet, By Product Type

2. Market Snippet, By Ablation Devices

3. Market Snippet, By Application

4. Market Snippet, By Region

4. Pain Management Devices Market Dynamics

1. Market Dynamics

1. Drivers

2. Restraints

2. Market Opportunities

3. Porter’s Five Analysis

4. Regulatory Analysis

5. Market Trends

6. Key Developments

5. Pain Management Devices Market - COVID Impact Analysis

6. Pain Management Devices Market - By Product Type

1. Introduction

1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

2. Market Attractiveness Index, By Product Type

2. Spinal Cord Stimulation (SCS) Devices

1. Introduction

2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

3. Stimulated Neuromodulator Devices

4. Transcutaneous Electrical Nerve Stimulation (TENS) Devices

7. Pain Management Devices Market - By Ablation Devices

1. Introduction

1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ablation Devices

2. Market Attractiveness Index, By Ablation Devices

2. Cryoablation Devices

1. Introduction

2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

3. Radiofrequency Ablation Devices

4. Analgesia Infusion Pumps

5. External Infusion pumps

6. Intrathecal Infusion Pumps

8. Pain Management Devices Market - By Application

1. Introduction

1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

2. Market Attractiveness Index, By Application

2. A migraine

1. Introduction

2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

3. Cancer Pain

4. Neuropathic Pain

5. Musculoskeletal Pain

6. Others (Facial, Trauma, etc.)

9. Pain Management Devices Market - By Region

1. Introduction

1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

2. Market Attractiveness Index, By Region

2. North America

1. Introduction

2. Key Region-Specific Dynamics

3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ablation Devices

5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

1. The U.S.

2. Canada

3. Mexico

3.  Europe

1. Introduction

2. Key Region-Specific Dynamics

3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ablation Devices

5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

1. Germany

2. The U.K.

3. France

4. Italy

5. Spain

6. Rest of Europe

4. South America

1. Introduction

2. Key Region-Specific Dynamics

3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ablation Devices

5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

1. Brazil

2. Argentina

3. Rest of South America

5. Asia-Pacific

1. Introduction

2. Key Region-Specific Dynamics

3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ablation Devices

5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

1. China

2. India

3. Japan

4. Australia

5. Rest of Asia-Pacific

6. The Middle East and Africa

1. Introduction

2. Key Region-Specific Dynamics

3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ablation Devices

5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

1. Competitive Scenario

2. Comparative Product Portfolio Analysis

3. Market Positioning/Share Analysis

4. Mergers and Acquisitions Analysis

5. SWOT Analysis

6. Company Profiles

1. Baxter International Inc.,

1. Company Overview

2. Product Portfolio

3. Financials

4. Key Developments

2. Abbott

3. B. Braun Melsungen AG

4. Boston Scientific Corporation

5. Codman and Shurtleff, Inc.

6. Axonics Modulation Technologies, Inc.

7. DJO Global LLC

8. NeuroMetrix, Inc.

9. Hospira Inc.

10. Kimberly-Clark Corporation

11. Medtronic, Plc

12. NeuroSigma, Inc.,

13. Smiths Medical

11. Appendix

1. About Us and Services

2. Related Reports

3. Contact Us

The market for Pain Management Devices has been significantly impacted by the COVID-19 outbreak. Due to the pandemic, the supply chain has been disrupted, demand has decreased as a result of postponed elective procedures, and healthcare priorities have changed to focus on treating COVID-19 patients. During the epidemic, a lot of elective treatments, including those for pain management, were put off in order to free up hospital space for COVID-19 patients. In some areas, this resulted in a decrease in the need for pain management devices.

Telehealth and remote monitoring technologies for pain management have seen an upsurge in popularity as a result of the pandemic. The number of in-person visits has decreased as a result of patients employing these technologies to interact with medical professionals and obtain treatment remotely. The management of COVID-19 has taken precedence in government policies and financing priorities, which may have an impact on the resources available for pain management research and development.